These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers. Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561 [TBL] [Abstract][Full Text] [Related]
6. Naloxone reversal of buprenorphine-induced respiratory depression. van Dorp E; Yassen A; Sarton E; Romberg R; Olofsen E; Teppema L; Danhof M; Dahan A Anesthesiology; 2006 Jul; 105(1):51-7. PubMed ID: 16809994 [TBL] [Abstract][Full Text] [Related]
7. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. Lewanowitsch T; Miller JH; Irvine RJ Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783 [TBL] [Abstract][Full Text] [Related]
9. Fentanyl depression of respiration: Comparison with heroin and morphine. Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594 [TBL] [Abstract][Full Text] [Related]
10. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids. Elder HJ; Walentiny DM; Beardsley PM Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364 [TBL] [Abstract][Full Text] [Related]
11. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest. van Lemmen M; Florian J; Li Z; van Velzen M; van Dorp E; Niesters M; Sarton E; Olofsen E; van der Schrier R; Strauss DG; Dahan A Anesthesiology; 2023 Sep; 139(3):342-353. PubMed ID: 37402248 [TBL] [Abstract][Full Text] [Related]
12. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest. Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413 [TBL] [Abstract][Full Text] [Related]
13. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B; Christoph T; Strassburger W; Friderichs E Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [TBL] [Abstract][Full Text] [Related]
14. Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice. Varga AG; Reid BT; Kieffer BL; Levitt ES J Physiol; 2020 Jan; 598(1):189-205. PubMed ID: 31589332 [TBL] [Abstract][Full Text] [Related]
15. Activation of μ-opioid receptors differentially affects the preBötzinger Complex and neighbouring regions of the respiratory network in the adult rabbit. Cinelli E; Bongianni F; Pantaleo T; Mutolo D Respir Physiol Neurobiol; 2020 Sep; 280():103482. PubMed ID: 32553889 [TBL] [Abstract][Full Text] [Related]
16. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000 [TBL] [Abstract][Full Text] [Related]
17. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil. Freye E; Neruda B; Smith OW Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435 [TBL] [Abstract][Full Text] [Related]
18. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. van der Schrier R; Dahan JDC; Boon M; Sarton E; van Velzen M; Niesters M; Dahan A Anesthesiology; 2022 Apr; 136(4):618-632. PubMed ID: 34958670 [TBL] [Abstract][Full Text] [Related]
19. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile. Kuo A; Wyse BD; Meutermans W; Smith MT Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546 [TBL] [Abstract][Full Text] [Related]
20. Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. Hajiha M; DuBord MA; Liu H; Horner RL J Physiol; 2009 Jun; 587(Pt 11):2677-92. PubMed ID: 19403616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]